Logo

2nd PGIVAC

2nd PGIVAC

23rd to 27th April 2018
Department of Community Medicine, School of Public Health, PGIMER


TECHNICAL PROGRAM


Time
Topic
Presenter
Day 1: 23/04/2018 Module 1: Introduction; & History of Vaccine development
8.00 - 9:00 am Registration  
9.00 – 9.30 am Inauguration
Welcome Address Inaugural address
Description of course objectives Vote of Thanks		   Dr Rajesh Kumar, Dean (Academics), PGIMER
Dr Jagat Ram, Director, PGIMER
Dr Madhu Gupta, Addl. Prof, SPH, PGIMER
Dr Manmeet Kaur, Addl. Professor, SPH, PGIMER
9.30-10.00 am Introduction of the participants Dr Madhu Gupta, Addl. Prof, SPH, PGIMER
10.00-10.30 am Tea Break  
10:00 – 10:30 am History of vaccines and vaccination Dr Rajesh Kumar, Prof and Head, SPH, Dean (Academics), PGIMER
10:30 – 11:00 am Case study 1: Small pox eradication
11:30 – 12:10 pm Role of disease burden assessment in the decision-making process Dr Madhu Gupta, Addl. Prof, SPH, PGIMER
12:10- 12:50 pm Impact of vaccination on disease epidemiology:  strategies to control, eliminate and eradicate vaccine preventable diseases Dr PVM lakshmi, Addl. Prof, SPH, PGIMER
12:50– 1:30 pm Polio endgame strategy, Measles elimination and Rubella control strategies Dr Shivani Gupta, Surveillance Medical Officer, WHO
1:30 -2:30 pm Lunch break  
2:30- 3:30 pm Implementation of evidence based vaccination policies in Indian Context: Recent updates in the National Immunization Schedule Dr Pradeep Haldar, Deputy Commissioner, Immunization division, Ministry of Health and Family welfare.
3:30 – 4:00 pm Experiences of implementing Rotavirus vaccine in Haryana State Dr Suresh Dalpath, State EPI officer, Haryana.
4:00 – 4:30 pm Tea  
4:30- 5:00 pm The role of vaccine industry in the development of Vaccine Dr Sajjad Desai, Deputy Medical Director, Serum Institute of India
Day 2: 24/04/2018 Module 2: Immunology related to Vaccines
8.30 - 9.00 am Recap of Day 1  
9:00 – 9.40 am What a vaccinologist should know about basic aspects of immune response: Innate, Cell mediated and humoral immune response Dr Biman Saikia, Professor Immunopathology, PGIMER
9.40 – 10.30 am Primary and secondary, innate and humoral immune responses Dr Ashwini Kumar Sood, Prof & head, Paediatrics, IGMC, Shimla.
10.30 – 11:00 am Tea break  
11:00 – 11:40 pm Vaccines affecting cell mediated immunity and special cases Dr Ritu Aggarwal, Addl. Prof, Immunopathology, PGIMER
11:40 – 12.30 pm Vaccination in special situations among children Dr Arun Bansal, Prof, Paediatrics, PGIMER
12:30- 1:00 pm Vaccination in special situations among adults: immuno-compromised individuals including HIV positive and hematological malignancies Dr Vikas Suri, Addl. Prof, Internal Medicine, PGIMER
1:00-1:30 pm Vaccination in special situations: Pregnancy Dr Vanita Suri, Prof and Head, Obstetrics and Gynaecology, PGIMER
1:30 – 2:30 pm Lunch break  
2:30 – 3:30 pm National vaccine policy: India Dr N.K. Ganguly, Former Director, ICMR
3:30 – 4:00 pm Tea break  
4:00 – 5:00 pm Group exercise 1: Rotavirus vaccine development (Immunology) Group 1: Dr Biman Saikia
Group 2: Dr Ashwini Kumar
Group 3: Dr Ritu Aggarwal
Group 4: Dr Sanjay Varma
Group 5: Dr Madhu Gupta
Day 3: 25/04/2018 Module 3: Regulations and Ethics; & Phases of Vaccine development
8.30 - 9.00 am Recap of Day 2  
9:00 – 9:40 am Regulations and Ethical considerations related to vaccine trials Dr Bikash Medhi, Professor, Department of Pharmacology, PGIMER
9:40 – 10:30 am Case study 2: Ethical issues in vaccine development
10:30 – 11:00 am Tea break  
11:00 – 11:30 am Preclinical safety testing of vaccines Dr Nusrat Shafiq, Addl. Prof, Pharmacology, PGIMER
11:30 – 12:00 am Introduction to statistical aspects of clinical trial (Defining sample size: practical approaches and example) Dr PVM lakshmi, Addl. Prof, SPH, PGIMER
12:00 –12:30 pm Phase I vaccine trials: methodology and implementation Dr Temsunaro Rongsen Chandola, Sr. Research Scientist, SAS
12:30 – 1:00 pm Phase II vaccine trials: methodology and implementation
1:00 – 2:00 pm Lunch break  
2:00 –3:00 pm Group exercise 2: How to design, recruit and analyze the results of phase I/II trials of rotavirus vaccine Group 1: Dr Nusrat Shafiq
Group 2: Dr Sunita Taneja
Group 3: Dr Nidhi Goyal
Group 4: Dr Sanjay Varma
Group 5: Dr Temsunrao Rongsen
3:00 – 3:30 pm Phase III vaccine trials: how to assess vaccine efficacy Dr Sunita Taneja, Deputy Director, SAS
3:00 – 3:30 pm Tea break
3:30 -  4:00 pm Population based post licensure surveillance and pharmacovigilence (Effectiveness studies) Dr Nidhi Goyal, Research Scientist SAS.
4:00 – 5:00 pm Group exercise 3: How to design, recruit and analyze the results of phase III trials of rotavirus vaccine Group 1: Dr Nusrat Shafiq
Group 2: Dr Sunita Taneja
Group 3: Dr Nidhi Goyal
Group 4: Dr Sanjay Varma
Group 5: Dr Temsunaro Rongsen
Day 4: 26/04/2018 Module 4: Introduction of vaccines in National Immunization Programs
8.30 - 9.00 am Recap of Day 3  
9:00 – 9:45 am New Vaccines introduction and Health systems strengthening Dr. Chandrakant Lahariya, National Professional Officer, WHO
09:45 – 10:30 am Advocacy in introduction of new vaccine Dr Manmeet Kaur, Addl. Professor, SPH, PGIMER
10:30 – 11:00 am Challenges and solutions in making evidence based national vaccination policies Dr Pankaj Bhatnagar, Technical Officer-Immunization, WHO India.  
11:00 – 11:30 am Tea break  
11:30 – 12:30 pm Health economics as a tool in analyzing vaccine policy option Mr. Pankaj Bahuguna, Economic Evaluation specialist, SPH, PGIMER
12:30 – 1:30 pm Panel Discussion: Introduction of newer vaccines in National Immunization Program
Chair: Dr Satish Gupta
Co Chair: Dr Chandrakant Lahariya 		Panelist
Dr Sanjay Varma
Dr Madhu Gupta
Dr Manmeet Kaur
Dr Bhavneet Bharti
1:30 – 2:30 pm Lunch break  
2:30 - 3.00 pm Procurement of vaccines: Role of GAVI, WHO, UNICEF Dr Satish Gupta,Health specialist, UNICEF
 3.00- 3.30 pm Assessing herd protection and vaccine effectiveness Dr Madhu Gupta, Addl. Prof, SPH, PGIMER
 3.30 – 4:00 pm Tea break  
 4:00- 5:00 pm Group exercise 4: Rationale and decision making for rotavirus vaccine introduction in national immunization program (review of cost effectiveness studies) Group 1: Dr Tarundeep Singh
Group 2: Mr. Pankaj Bahuguna
Group 3: Dr PVM Lakshmi
Group 4: Dr Sanjay Verma
Group 5: Dr Madhu Gupta
Day 5: 27/04/2018 Module 5: Update on Current and Newer Vaccines
8.30 to 9.00 am Recap of Day 4
9:00 – 9.30 am Learnings from MR vaccination campaign Dr Bhavneet Bharti, Prof, Paediatrics, PGIMER.
9.30 – 10.00 am Licensed vaccines in children: Pneumoccoal, Hexavalent vaccines, Typhoid vaccines Dr Sanjay Varma, Addl. Prof, Paediatrics, PGIMER
10.00-10.30 am Licensed Vaccines: HPV for cervical cancer, Pneumococcal vaccines for pneumonia, Shancol for cholera, Hepatitis A vaccine, Influenza vaccines Dr Ashish Bhalla, Prof, Internal Medicine, PGIMER
10.30– 11:00 am Tea break  
11:00 – 11.30 am Vaccines in development phase: HIV/AIDS, TB and malaria vaccines, Dengue Dr Vikas Suri, Addl. Prof, Internal Medicine, PGIMER
11.30- 1:30 pm Participant’s presentation of group work Group facilitators.
1.30-2.00 pm Valedictory  
2.00 pm Lunch